.png){kind=icon}
返回
Elevated plasma complement components in facioscapulohumeral dystrophy
.png){kind=icon}
OA
AI
DOI：10.1093/hmg/ddab364.png)
.png){kind=icon}
原文求助.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
Advances in understanding the pathophysiology of facioscapulohumeral dystrophy (FSHD) have led to several therapeutic approaches entering clinical trials and an increased need to develop biomarkers of disease activity and progression. Multiple prior studies have shown early elevation of RNAs encoding components of the complement pathways and relatively widespread activated complement complexes by immunodetection in FSHD muscle. The current study tested plasma from two independent cohorts of FSHD and control subjects and found elevated complement components in both FSHD cohorts. Combining subjects from both cohorts identified complement factors that best distinguished FSHD and controls. Within the FSHD group, a subset of subjects showed elevation in multiple complement components. Together these findings suggest the need for future studies to determine whether measurements of complement activation can be used as a non-invasive measurement of FSHD disease activity, progression and/or response to therapies. In addition, with the ongoing expansion of complement therapeutic approaches, consideration for precision-based targeting of this pathway is appropriate.
Keyword:
MUSCULAR-DYSTROPHY
FSHD
期刊
IF:
3.2
论文数:
1.1W
被引数:
3.5W
机构
引用论文
Conserved roles of mouse DUX and human DUX4 in activating cleavage-stage genes and MERVL/HERVL retrotransposons.png)
NATURE GENETICS
OAAI
NATURE GENETICSIF31.8
OAAI分享收藏MRI-informed muscle biopsies correlate MRI with pathology and DUX4 target gene expression in FSHDOAAI
OAAI分享收藏Characterization of a Medium Wavelength Type DNA Photolyase: Purification and Properties of Photolyase from Bacillus firmusBiochemistry
BiochemistryIF0
PREAI
分享收藏
查看更多内容